Cargando…

Erratum: Advances in RIPK1 kinase inhibitors

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9868424/
https://www.ncbi.nlm.nih.gov/pubmed/36699094
http://dx.doi.org/10.3389/fphar.2022.1123234
_version_ 1784876534170910720
collection PubMed
description
format Online
Article
Text
id pubmed-9868424
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-98684242023-01-24 Erratum: Advances in RIPK1 kinase inhibitors Front Pharmacol Pharmacology Frontiers Media S.A. 2023-01-09 /pmc/articles/PMC9868424/ /pubmed/36699094 http://dx.doi.org/10.3389/fphar.2022.1123234 Text en Copyright © 2023 Frontiers Production Office. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Erratum: Advances in RIPK1 kinase inhibitors
title Erratum: Advances in RIPK1 kinase inhibitors
title_full Erratum: Advances in RIPK1 kinase inhibitors
title_fullStr Erratum: Advances in RIPK1 kinase inhibitors
title_full_unstemmed Erratum: Advances in RIPK1 kinase inhibitors
title_short Erratum: Advances in RIPK1 kinase inhibitors
title_sort erratum: advances in ripk1 kinase inhibitors
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9868424/
https://www.ncbi.nlm.nih.gov/pubmed/36699094
http://dx.doi.org/10.3389/fphar.2022.1123234
work_keys_str_mv AT erratumadvancesinripk1kinaseinhibitors